MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
mltx · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, MoonLake Immunotherapeutics (MLTX) has a market cap — also referred to as its net worth or valuation — of $1.3B, making it one of the top most valuable companies globally. Market Cap = $18.02 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
MoonLake Immunotherapeutics (MLTX) has a market cap — also referred to as its net worth or valuation — of $1.3B as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
MoonLake Immunotherapeutics reached its all-time high market cap of $3.4B on Dec 31, 2024. Comparing the MoonLake Immunotherapeutics market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare MoonLake Immunotherapeutics net worth vs peers and ask how MoonLake Immunotherapeutics valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
MLTX market cap · 6 questionsMoonLake Immunotherapeutics's net worth — measured as market capitalization — is $1.3B as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$18.02 (price) × shares outstanding.